This report contains market size and forecasts of Drugs for Duchenne Muscular Dystrophy (DMD) in Global, including the following market information:
Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drugs for Duchenne Muscular Dystrophy (DMD) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Eteplirsen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Duchenne Muscular Dystrophy (DMD) include Sarepta Therapeutics, PTC Therapeutics, Pfizer, Bristol-Myers Squibb, Italfarmaco, Santhera Pharmaceuticals and WaVe life Science, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Duchenne Muscular Dystrophy (DMD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Duchenne Muscular Dystrophy (DMD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Segment Percentages, by Type, 2021 (%)
Eteplirsen
Deflazacort
Ataluren
Global Drugs for Duchenne Muscular Dystrophy (DMD) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home Care
Global Drugs for Duchenne Muscular Dystrophy (DMD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Duchenne Muscular Dystrophy (DMD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drugs for Duchenne Muscular Dystrophy (DMD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
WaVe life Science